Benchmark Capital Advisors Buys BK Technologies Inc, Merck Inc, Newell Brands Inc, Sells Bristol-Myers Squibb Company, Viasat Inc, iShares Europe

• New Purchases: BKTI, MRK, NWL, PG, CMCSA, DVMT, CAT, LGF.B, AABA, IYY,
• Added Positions: FB, AAPL, GOOG, ROKU, GE, JNJ, AERI, CEMI, T, KKR,
• Reduced Positions: BMY, SRPT, PFE, GM, MDLZ, MSFT, BABA, DXJ, PHYS, C,
• Sold Out: VSAT, IEV, NVS, JCI, VGK, CL, MU, PPA, MCD,

For the details of Benchmark Capital Advisors's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Benchmark+Capital+Advisors

1. Apple Inc (AAPL) - 37,991 shares, 5.5% of the total portfolio. Shares added by 17.38%
2. BK Technologies Inc (BKTI) - 1,484,948 shares, 4.3% of the total portfolio. New Position
3. KKR & Co Inc (KKR) - 178,463 shares, 3.47% of the total portfolio. Shares added by 4.66%
4. Arbor Realty Trust Inc (ABR) - 403,519 shares, 3.29% of the total portfolio. Shares added by 3.78%
5. General Motors Co (GM) - 104,593 shares, 3.22% of the total portfolio. Shares reduced by 5.85%

Benchmark Capital Advisors initiated holding in BK Technologies Inc. The purchase prices were between $3.4 and $4, with an estimated average price of $3.77. The stock is now traded at around $3.70. The impact to a portfolio due to this purchase was 4.3%. The holding were 1,484,948 shares as of 2018-06-30.

Benchmark Capital Advisors initiated holding in Merck & Co Inc. The purchase prices were between $53.27 and $62.59, with an estimated average price of $59.12. The stock is now traded at around $63.66. The impact to a portfolio due to this purchase was 1.32%. The holding were 27,750 shares as of 2018-06-30.

Benchmark Capital Advisors initiated holding in Newell Brands Inc. The purchase prices were between $23.12 and $27.74, with an estimated average price of $26.08. The stock is now traded at around $25.56. The impact to a portfolio due to this purchase was 0.9%. The holding were 44,560 shares as of 2018-06-30.

Benchmark Capital Advisors initiated holding in Procter & Gamble Co. The purchase prices were between $70.94 and $79.05, with an estimated average price of $75.29. The stock is now traded at around $79.09. The impact to a portfolio due to this purchase was 0.61%. The holding were 10,000 shares as of 2018-06-30.

Benchmark Capital Advisors initiated holding in Comcast Corp. The purchase prices were between $30.59 and $34.6, with an estimated average price of $32.61. The stock is now traded at around $32.86. The impact to a portfolio due to this purchase was 0.58%. The holding were 22,775 shares as of 2018-06-30.

Benchmark Capital Advisors initiated holding in Dell-VMWare Tracking Stock. The purchase prices were between $70.7 and $89.57, with an estimated average price of $78.71. The stock is now traded at around $93.64. The impact to a portfolio due to this purchase was 0.2%. The holding were 3,000 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in Facebook Inc by 153.29%. The purchase prices were between $155.1 and $202, with an estimated average price of $180.53. The stock is now traded at around $217.38. The impact to a portfolio due to this purchase was 0.88%. The holding were 9,625 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in Alphabet Inc by 185.00%. The purchase prices were between $1006.47 and $1173.46, with an estimated average price of $1080.62. The stock is now traded at around $1255.25. The impact to a portfolio due to this purchase was 0.8%. The holding were 1,425 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in Roku Inc by 194.33%. The purchase prices were between $30.29 and $46.75, with an estimated average price of $36.46. The stock is now traded at around $47.98. The impact to a portfolio due to this purchase was 0.6%. The holding were 27,414 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in General Electric Co by 65.80%. The purchase prices were between $12.75 and $15.29, with an estimated average price of $13.92. The stock is now traded at around $13.00. The impact to a portfolio due to this purchase was 0.35%. The holding were 83,025 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in Johnson & Johnson by 78.09%. The purchase prices were between $119.4 and $131.76, with an estimated average price of $124.84. The stock is now traded at around $128.20. The impact to a portfolio due to this purchase was 0.3%. The holding were 7,298 shares as of 2018-06-30.

Benchmark Capital Advisors added to a holding in Chembio Diagnostics Inc by 28.16%. The purchase prices were between $7.8 and $11.1, with an estimated average price of $8.98. The stock is now traded at around $11.25. The impact to a portfolio due to this purchase was 0.18%. The holding were 96,235 shares as of 2018-06-30.

Benchmark Capital Advisors sold out a holding in Viasat Inc. The sale prices were between $61.78 and $67.04, with an estimated average price of $63.8.

Benchmark Capital Advisors sold out a holding in iShares Europe. The sale prices were between $44.12 and $48.3, with an estimated average price of $47.

Benchmark Capital Advisors sold out a holding in Novartis AG. The sale prices were between $72.44 and $81.87, with an estimated average price of $77.05.

Benchmark Capital Advisors sold out a holding in Johnson Controls International PLC. The sale prices were between $33.26 and $36.72, with an estimated average price of $34.76.

Benchmark Capital Advisors sold out a holding in Vanguard FTSEEuropean. The sale prices were between $55.43 and $60.28, with an estimated average price of $58.82.

Benchmark Capital Advisors sold out a holding in Colgate-Palmolive Co. The sale prices were between $61.65 and $72.44, with an estimated average price of $65.45.